These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1432625)

  • 41. In vitro release and intestinal absorption of physostigmine salicylate from submicron emulsions.
    Rubinstein A; Pathak YV; Kleinstern J; Reches A; Benita S
    J Pharm Sci; 1991 Jul; 80(7):643-7. PubMed ID: 1941560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Percutaneous absorption of nonsteroidal anti-inflammatory preparations].
    Pratzel HG
    Ter Arkh; 1990; 62(5):98-103. PubMed ID: 2396226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of constant current alternating current iontophoresis for transdermal drug delivery.
    Yan G; Li SK; Higuchi WI
    J Control Release; 2005 Dec; 110(1):141-50. PubMed ID: 16289410
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of epidermal turnover on the dynamics of percutaneous drug absorption.
    Simon L; Kim KS; Kanneganti K
    Math Biosci; 2011 Jan; 229(1):16-21. PubMed ID: 21040736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In-vitro model for assessing glucose diffusion through skin.
    Ullah S; Hamade F; Bubniene U; Engblom J; Ramanavicius A; Ramanaviciene A; Ruzgas T
    Biosens Bioelectron; 2018 Jul; 110():175-179. PubMed ID: 29609166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prediction of cathodal iontophoretic transport of various anions across excised skin from different vehicles using conductivity measurements.
    Yoshida NH; Roberts MS
    J Pharm Pharmacol; 1995 Nov; 47(11):883-90. PubMed ID: 8708980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Percutaneous absorption of sunscreen agents from liquid paraffin: self-association of octyl salicylate and effects on skin flux.
    Jiang R; Roberts MS; Prankerd RJ; Benson HA
    J Pharm Sci; 1997 Jul; 86(7):791-6. PubMed ID: 9232518
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Facilitated transport of sodium salicylate across an artificial lipid membrane by Azone.
    Hadgraft J; Walters KA; Wotton PK
    J Pharm Pharmacol; 1985 Oct; 37(10):725-7. PubMed ID: 2867142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies.
    Cross SE; Anderson C; Roberts MS
    Br J Clin Pharmacol; 1998 Jul; 46(1):29-35. PubMed ID: 9690946
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects.
    Benfeldt E
    Acta Derm Venereol Suppl (Stockh); 1999; 206():1-59. PubMed ID: 10605601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of physostigmine in man following a single application of a transdermal system.
    Walter K; Müller M; Barkworth MF; Nieciecki AV; Stanislaus F
    Br J Clin Pharmacol; 1995 Jan; 39(1):59-63. PubMed ID: 7756100
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamics and control of percutaneous drug absorption in the presence of epidermal turnover.
    Simon L; Goyal A
    J Pharm Sci; 2009 Jan; 98(1):187-204. PubMed ID: 18481307
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Use of a molecular form technique for the penetration of supersaturated solutions of salicylic acid across silicone membranes and human skin in vitro.
    Leveque N; Raghavan SL; Lane ME; Hadgraft J
    Int J Pharm; 2006 Aug; 318(1-2):49-54. PubMed ID: 16650701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Establishment and application of in situ perfused pig ear model for percutaneous absorption].
    Hu JH; Zhu QG; Shen Q
    Yao Xue Xue Bao; 2003 Oct; 38(10):783-6. PubMed ID: 14730905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using the method of homogenization to calculate the effective diffusivity of the stratum corneum with permeable corneocytes.
    Rim JE; Pinsky PM; van Osdol WW
    J Biomech; 2008; 41(4):788-96. PubMed ID: 18093598
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diffusion modeling of percutaneous absorption kinetics: 3. Variable diffusion and partition coefficients, consequences for stratum corneum depth profiles and desorption kinetics.
    Anissimov YG; Roberts MS
    J Pharm Sci; 2004 Feb; 93(2):470-87. PubMed ID: 14705203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transdermal penetration of vasoconstrictors--present understanding and assessment of the human epidermal flux and retention of free bases and ion-pairs.
    Cross SE; Thompson MJ; Roberts MS
    Pharm Res; 2003 Feb; 20(2):270-4. PubMed ID: 12636167
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting skin penetration of actives from complex cosmetic formulations: an evaluation of inter formulation and inter active effects during formulation optimization for transdermal delivery.
    Wiechers JW; Watkinson AC; Cross SE; Roberts MS
    Int J Cosmet Sci; 2012 Dec; 34(6):525-35. PubMed ID: 22950455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Penetration kinetics of xanthotoxin across human skin and stratum corneum].
    Wang LY; Jöelle M; Huang FF; Yang DP
    Yao Xue Xue Bao; 2006 Sep; 41(9):878-81. PubMed ID: 17111837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic enhancement of papaverine transdermal gel for erectile dysfunction.
    Wen MM; El-Kamel AH; Khalil SA
    Drug Dev Ind Pharm; 2012 Aug; 38(8):912-22. PubMed ID: 22080854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.